191 related articles for article (PubMed ID: 32642389)
1. Potential Protein Biomarkers for Preeclampsia.
He A; Zhou Y; Wei Y; Li R
Cureus; 2020 Jun; 12(6):e8925. PubMed ID: 32642389
[TBL] [Abstract][Full Text] [Related]
2. Serum protein profile analysis via label-free quantitation proteomics in patients with early-onset preeclampsia.
Ji Q; Zhang S; Jiang W; Wang J; Luan Y; Xin Q
J Obstet Gynaecol; 2023 Dec; 43(2):2259982. PubMed ID: 37743728
[TBL] [Abstract][Full Text] [Related]
3. [Identification of proteomic biomarkers of preeclampsia using protein microarray and tandem mass spectrometry].
Charkiewicz K; Jasinska E; Laudanski P
Postepy Hig Med Dosw (Online); 2015 May; 69():562-70. PubMed ID: 25983295
[TBL] [Abstract][Full Text] [Related]
4. Using proteomics to advance the search for potential biomarkers for preeclampsia: A systematic review and meta-analysis.
Nguyen TPH; Patrick CJ; Parry LJ; Familari M
PLoS One; 2019; 14(4):e0214671. PubMed ID: 30951540
[TBL] [Abstract][Full Text] [Related]
5. Systematic proteomics analysis of lysine acetylation reveals critical features of placental proteins in pregnant women with preeclampsia.
Shangguan Y; Wang Y; Shi W; Guo R; Zeng Z; Hu W; Cai W; Yan Q; Xu Y; Tang D; Dai Y
J Cell Mol Med; 2021 Nov; 25(22):10614-10626. PubMed ID: 34697885
[TBL] [Abstract][Full Text] [Related]
6. First trimester serum biomarker discovery study for early onset, preterm onset and preeclampsia at term.
Beernink RHJ; Zwertbroek EF; Schuitemaker JHN; Cremers TIFH; Scherjon SA
Placenta; 2022 Oct; 128():39-48. PubMed ID: 36058050
[TBL] [Abstract][Full Text] [Related]
7. Urine proteomic studies in preeclampsia.
Kolialexi A; Mavreli D; Tounta G; Mavrou A; Papantoniou N
Proteomics Clin Appl; 2015 Jun; 9(5-6):501-6. PubMed ID: 25644222
[TBL] [Abstract][Full Text] [Related]
8. Identification of Biomarkers for Preeclampsia Based on Metabolomics.
Yao M; Xiao Y; Yang Z; Ge W; Liang F; Teng H; Gu Y; Yin J
Clin Epidemiol; 2022; 14():337-360. PubMed ID: 35342309
[TBL] [Abstract][Full Text] [Related]
9. Screening of differentially expressed proteins in placentas from patients with late-onset preeclampsia.
He A; Wang J; Yang X; Liu J; Yang X; Wang G; Li R
Proteomics Clin Appl; 2022 Mar; 16(2):e2100053. PubMed ID: 34704665
[TBL] [Abstract][Full Text] [Related]
10. A systematic review on the application of vascular endothelial growth factors in preeclampsia.
Liu Y; Ren M; Bi X; Fu Y; Jing X; Zhang H; Cao B; Wang C
Ann Palliat Med; 2021 Aug; 10(8):9259-9266. PubMed ID: 34488411
[TBL] [Abstract][Full Text] [Related]
11. ST2 and galectin-3 as novel biomarkers for the prediction of future cardiovascular disease risk in preeclampsia.
Atakul N; Atamer Y; Selek Ş; Kılıç B; Koktasoglu F
J Obstet Gynaecol; 2022 Jul; 42(5):1023-1029. PubMed ID: 34930081
[TBL] [Abstract][Full Text] [Related]
12. Peptidome Analysis of Human Serum From Normal and Preeclamptic Pregnancies.
Dai X; Song X; Rui C; Meng L; Xue X; Ding H; Shen R; Li J; Li J; Lu Y; Long W
J Cell Biochem; 2017 Dec; 118(12):4341-4348. PubMed ID: 28430386
[TBL] [Abstract][Full Text] [Related]
13. Screening of serum biomarkers of preeclampsia by proteomics combination with bioinformatics.
Ling Y; Su J; Lin J; Wang S
Hypertens Pregnancy; 2019 Aug; 38(3):184-192. PubMed ID: 31284791
[No Abstract] [Full Text] [Related]
14. Proteomic signatures predict preeclampsia in individual cohorts but not across cohorts - implications for clinical biomarker studies.
Ghaemi MS; Tarca AL; Romero R; Stanley N; Fallahzadeh R; Tanada A; Culos A; Ando K; Han X; Blumenfeld YJ; Druzin ML; El-Sayed YY; Gibbs RS; Winn VD; Contrepois K; Ling XB; Wong RJ; Shaw GM; Stevenson DK; Gaudilliere B; Aghaeepour N; Angst MS
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5621-5628. PubMed ID: 33653202
[TBL] [Abstract][Full Text] [Related]
15. Early Gestational Blood Markers to Predict Preeclampsia Complicating Gestational Diabetes Mellitus.
Xie Y; Zhou W; Tao X; Lv H; Cheng Z
Diabetes Metab Syndr Obes; 2023; 16():1493-1503. PubMed ID: 37252009
[TBL] [Abstract][Full Text] [Related]
16. Combination of copeptin, placental growth factor and total annexin V microparticles for prediction of preeclampsia at 10-14 weeks of gestation.
Jadli A; Ghosh K; Satoskar P; Damania K; Bansal V; Shetty S
Placenta; 2017 Oct; 58():67-73. PubMed ID: 28962698
[TBL] [Abstract][Full Text] [Related]
17. Plasma Olink Proteomics Identifies CCL20 as a Novel Predictive and Diagnostic Inflammatory Marker for Preeclampsia.
Wang X; Yip KC; He A; Tang J; Liu S; Yan R; Zhang Q; Li R
J Proteome Res; 2022 Dec; 21(12):2998-3006. PubMed ID: 36301636
[TBL] [Abstract][Full Text] [Related]
18. Proteomics and Metabolomics Profiling of Platelets and Plasma Mediators of Thrombo-Inflammation in Gestational Hypertension and Preeclampsia.
de Almeida LGN; Young D; Chow L; Nicholas J; Lee A; Poon MC; Dufour A; Agbani EO
Cells; 2022 Apr; 11(8):. PubMed ID: 35455936
[TBL] [Abstract][Full Text] [Related]
19. Application of metabolomics to preeclampsia diagnosis.
Nobakht M Gh BF
Syst Biol Reprod Med; 2018 Oct; 64(5):324-339. PubMed ID: 29965778
[TBL] [Abstract][Full Text] [Related]
20. Screening of differentially expressed proteins from syncytiotrophoblast for severe early-onset preeclampsia in women with gestational diabetes mellitus using tandem mass tag quantitative proteomics.
Sun X; Qu T; He X; Yang X; Guo N; Mao Y; Xu X; Sun X; Zhang X; Wang W
BMC Pregnancy Childbirth; 2018 Nov; 18(1):437. PubMed ID: 30404616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
